Nkarta

$28.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.87 (+10.62%) Today
-$1.00 (-3.34%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Nkarta and other stocks, options, and ETFs commission-free!

About NKTX

Nkarta, Inc. Common Stock, also called Nkarta, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. Read More The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA. The listed name for NKTX is Nkarta, Inc. Common Stock.

Employees
Headquarters
South San Francisco, California
Founded
2005
Market Cap
976.96M
Price-Earnings Ratio
Dividend Yield
Average Volume
217.05K
High Today
$30.49
Low Today
$26.03
Open Price
$27.14
Volume
208.28K
52 Week High
$58.69
52 Week Low
$22.46

Collections

You May Also Like